S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?

Aclaris Therapeutics (ACRS) Insider Trading & Ownership

$1.21
0.00 (0.00%)
(As of 04/15/2024 ET)

Aclaris Therapeutics (NASDAQ:ACRS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$99,994.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$136,080.00
Get ACRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aclaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACRS Insider Buying and Selling by Quarter

Aclaris Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/23/2023Joseph MonahanInsiderSell6,000$5.08$30,480.00  
8/28/2023James LoeropInsiderBuy14,705$6.80$99,994.00  
8/21/2023Joseph MonahanInsiderSell6,000$7.32$43,920.00  
6/20/2023Joseph MonahanInsiderSell6,000$10.28$61,680.00  
(Data available from 1/1/2013 forward)

ACRS Insider Trading Activity - Frequently Asked Questions

Who is on Aclaris Therapeutics's Insider Roster?

The list of insiders at Aclaris Therapeutics includes Andrew N Schiff, David N Gordon, Douglas J Manion, Frank Ruffo, James Loerop, Joseph Monahan, Kamil Ali-Jackson, Kevin Balthaser, and Neal Walker. Learn more on insiders at ACRS.

What percentage of Aclaris Therapeutics stock is owned by insiders?

5.50% of Aclaris Therapeutics stock is owned by insiders. Learn more on ACRS's insider holdings.

Which Aclaris Therapeutics insiders have been buying company stock?

The following insiders have purchased ACRS shares in the last 24 months: Douglas J Manion ($50,310.00), and James Loerop ($99,994.00).

How much insider buying is happening at Aclaris Therapeutics?

Insiders have purchased a total of 21,205 ACRS shares in the last 24 months for a total of $150,304.00 bought.

Which Aclaris Therapeutics insiders have been selling company stock?

The following insiders have sold ACRS shares in the last 24 months: Andrew N Schiff ($1,565,033.42), James Loerop ($59,268.63), Joseph Monahan ($966,856.00), Kevin Balthaser ($12,290.00), and Neal Walker ($1,424,580.00).

How much insider selling is happening at Aclaris Therapeutics?

Insiders have sold a total of 291,271 Aclaris Therapeutics shares in the last 24 months for a total of $4,324,242.15 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ACRS) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners